Display Options:
Total: 1496
Small molecule
Approved
OTHER
ORAL
Central Nervous System Neoplasms; Cystadenocarcinoma, Serous; Esophageal Neoplasms; Head and Neck Neoplasms; Hereditary Breast and Ovarian Cancer Syndrome; Hypertension, Pulmonary; Inflammatory Breast Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Neoplasm Metastasis; Neuroendocrine Tumors; Rhabdomyosarcoma; Squamous Cell Carcinoma of Head and Neck; Uterine Neoplasms; Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinosarcoma; Cholangiocarcinoma; Colorectal Neoplasms; Fallopian Tube Neoplasms; Glioblastoma; Glioma; Hemangiosarcoma; Leiomyosarcoma; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Peripheral; Melanoma; Mesothelioma; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Osteosarcoma; Peritoneal Neoplasms; Pheochromocytoma; Sarcoma; Sarcoma, Ewing; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uveal Melanoma; Carcinoma; Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Lung Neoplasms; Prostatic Neoplasms; Small Cell Lung Carcinoma; Stomach Neoplasms; Breast Neoplasms; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
PARP 1, 2 and 3 inhibitor
Small molecule
Approved
CANCER; HEMATOLOGY; OTHER
ORAL
Carcinoma, Pancreatic Ductal; Leukemia, Myeloid, Acute; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Rhinitis, Allergic, Seasonal; Amyloidosis; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Waldenstrom Macroglobulinemia; Lymphoma; Lymphoma, Follicular; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Neoplasms
PI3-kinase p110-delta subunit inhibitor
Antibody
Approved
IMMUNE SYSTEM; OTHER
INJECTION
Carcinoma, Renal Cell; Diabetes Mellitus, Type 1; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Paraproteinemias; Schizophrenia; Kidney Neoplasms; Myelodysplastic Syndromes; Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Severe Acute Respiratory Syndrome; Castleman Disease; Immune System Diseases
Interleukin-6 antagonist
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Orthostatic Intolerance; Attention Deficit Disorder with Hyperactivity; Fibromyalgia; Hypotension; Parkinson Disease; Cardiovascular Diseases; Hypotension, Orthostatic; Multiple System Atrophy
Adrenergic receptor agonist
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Acute Kidney Injury; Crohn Disease; Diabetic Neuropathies; Epilepsy; Inflammatory Bowel Diseases; Ascites; Colitis, Ulcerative; Depressive Disorder, Major; Familial Primary Pulmonary Hypertension; Glycogen Storage Disease Type I; Hypertension, Portal; Hypoglycemia; Hyponatremia; Inappropriate ADH Syndrome; Kidney Calculi; Kidney Diseases; Kidney Failure, Chronic; Neoplasms; Polycystic Kidney, Autosomal Dominant; Polycystic Ovary Syndrome; Prediabetic State; ST Elevation Myocardial Infarction; Cardiotoxicity; Diabetes, Gestational; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Insulin Resistance; Metabolic Syndrome; Myocardial Infarction; Non-alcoholic Fatty Liver Disease; Severe Acute Respiratory Syndrome; Shock; Diabetes Mellitus; Diabetes Mellitus, Type 2; Heart Failure; Renal Insufficiency, Chronic
Sodium/glucose cotransporter 2 inhibitor
Small molecule
Approved
DERMATOLOGY; IMMUNE SYSTEM; OTHER; RHEUMATOLOGY
ORAL; UNKNOWN
Lupus Erythematosus, Discoid; Uveitis; Acne Vulgaris; Alcoholism; Arthritis, Rheumatoid; Colitis, Ulcerative; Dermatitis; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dermatomyositis; Eczema; Erythema Multiforme; Gout; Hidradenitis Suppurativa; Lichen Planus; Lichen Planus, Oral; Prostatitis; Rosacea; Vitiligo; Influenza, Human; Pneumonia; Severe Acute Respiratory Syndrome; Spondylitis, Ankylosing; Arthritis, Psoriatic; Behcet Syndrome; Immune System Diseases; Oral Ulcer; Psoriasis
Phosphodiesterase 4 inhibitor
Antibody
Approved
GASTROINTESTINAL; OTHER
INJECTION
Desmoplastic Small Round Cell Tumor; Glioma; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Sarcoma, Synovial; Adenocarcinoma; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Glioblastoma; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Mesothelioma; Mesothelioma, Malignant; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Thymoma; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Stomach Neoplasms
Vascular endothelial growth factor receptor 2 inhibitor
Small molecule
Approved
OTHER
ORAL
Renal Insufficiency, Chronic; Anemia; Hyperphosphatemia
Phosphate sequestering agent
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Aging; Alzheimer Disease; Brain Neoplasms; Lupus Nephritis; Myocardial Ischemia; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Reperfusion Injury; Albuminuria; Amyloidosis, Familial; Breast Neoplasms; Cystinuria; Depressive Disorder; Diabetic Nephropathies; Diabetic Neuropathies; Fabry Disease; Heart Failure, Diastolic; Hypertension, Pulmonary; Hyperuricemia; Inflammatory Bowel Diseases; Liver Cirrhosis; Metabolic Syndrome; Motor Activity; Myocardial Infarction; Obesity; Weight Loss; Acute Kidney Injury; Atrial Fibrillation; Coronary Disease; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Fatty Liver; Glomerulonephritis, IGA; Insulin Resistance; Kidney Failure, Chronic; Non-alcoholic Fatty Liver Disease; Polycystic Ovary Syndrome; Renal Insufficiency; Severe Acute Respiratory Syndrome; ST Elevation Myocardial Infarction; Diabetes Mellitus; Diabetes Mellitus, Type 2; Heart Failure; Renal Insufficiency, Chronic
Sodium/glucose cotransporter 2 inhibitor
Small molecule
Approved
OTHER
ORAL
Urticaria; Bipolar Disorder; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Trypanosomiasis
Unknown
Protein
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
INJECTION
Hyperparathyroidism; Psoriasis; Osteoporosis; Hypocalcemia; Hypoparathyroidism; Osteoporosis, Postmenopausal
Parathyroid hormone receptor agonist
Small molecule
Approved
OTHER
INTRAVENOUS
Renal Insufficiency; Anemia, Iron-Deficiency; Renal Insufficiency, Chronic
Supplement
Combination
Approved
OTHER
INTRAMUSCULAR; ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
IMMUNE SYSTEM; OTHER
ORAL
Unknown
Unknown
Unknown
Approved
OTHER
INJECTION
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
CANCER; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Combination
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Unknown
Unknown
Combination
Approved
OTHER
OTIC
Unknown
Unknown
Combination
Approved
OTHER
OTIC
Unknown
Unknown